Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Acquarone

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Alzheimer'S Disease : JAD|June 15, 2026
Neuronal resilience as an active and programmable propertyErica Acquarone
Nutrients|June 28, 2017
Vitamin C, Aging and Alzheimer's DiseaseFiammetta Monacelli, Erica Acquarone, Chiara Giannotti, et al.
Cells|February 12, 2026
The Highly Selective 5-HT<sub>2B</sub> Receptor Antagonist MW073 Mitigates Aggressive Behavior in an Alzheimer's Disease Mouse ModelErica Acquarone, Saktimayee M Roy, Agnieszka Staniszewski, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2024
The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced DysfunctionErica Acquarone, Elentina K Argyrousi, Ottavio Arancio, et al.
Biochemical Pharmacology|January 25, 2020
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's diseaseElisa Zuccarello, Erica Acquarone, Elisa Calcagno, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2023
Optimizing metabolic stability of phosphodiesterase 5 inhibitors: Discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticityElisa Zuccarello, Hong Zhang, Erica Acquarone, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 28, 2025
Optimized 5-HT<sub>2b</sub> inhibitors for neuropsychiatric syndromes with cognitive dysfunctionSaktimayee M Roy, Erica Acquarone, Elentina K Argyrousi, et al.
Progress in Neurobiology|June 15, 2023
Intracellular accumulation of tau oligomers in astrocytes and their synaptotoxic action rely on Amyloid Precursor Protein Intracellular Domain-dependent expression of Glypican-4Giulia Puliatti, Domenica Donatella Li Puma, Giuseppe Aceto, et al.
Molecular Neurodegeneration|June 29, 2019
Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascadeErica Acquarone, Elentina K Argyrousi, Manon van den Berg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 6, 2025
Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's diseaseLuana Fioriti, Nadeeja Wijesekara, Elentina K Argyrousi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Alzheimer'S Disease : JAD|June 15, 2026
Neuronal resilience as an active and programmable propertyErica Acquarone
Nutrients|June 28, 2017
Vitamin C, Aging and Alzheimer's DiseaseFiammetta Monacelli, Erica Acquarone, Chiara Giannotti, et al.
Cells|February 12, 2026
The Highly Selective 5-HT<sub>2B</sub> Receptor Antagonist MW073 Mitigates Aggressive Behavior in an Alzheimer's Disease Mouse ModelErica Acquarone, Saktimayee M Roy, Agnieszka Staniszewski, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2024
The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced DysfunctionErica Acquarone, Elentina K Argyrousi, Ottavio Arancio, et al.
Biochemical Pharmacology|January 25, 2020
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's diseaseElisa Zuccarello, Erica Acquarone, Elisa Calcagno, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2023
Optimizing metabolic stability of phosphodiesterase 5 inhibitors: Discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticityElisa Zuccarello, Hong Zhang, Erica Acquarone, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 28, 2025
Optimized 5-HT<sub>2b</sub> inhibitors for neuropsychiatric syndromes with cognitive dysfunctionSaktimayee M Roy, Erica Acquarone, Elentina K Argyrousi, et al.
Progress in Neurobiology|June 15, 2023
Intracellular accumulation of tau oligomers in astrocytes and their synaptotoxic action rely on Amyloid Precursor Protein Intracellular Domain-dependent expression of Glypican-4Giulia Puliatti, Domenica Donatella Li Puma, Giuseppe Aceto, et al.
Molecular Neurodegeneration|June 29, 2019
Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascadeErica Acquarone, Elentina K Argyrousi, Manon van den Berg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 6, 2025
Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's diseaseLuana Fioriti, Nadeeja Wijesekara, Elentina K Argyrousi, et al.
Pageof 2